UPDATE 1-SoftBank-backed Vir Biotechnology raises $143 mln in U.S. IPO . Vir Biotechnology priced its initial public offering (IPO) at $20 a share on Thursday, at the bottom end of expectations, the latest underwhelming investment performance for a stock held by SoftBank Group Corp's Vision Fund.